Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Urothelial Cancer/Enfortumab Vedotin

Evan Yu

MD

🏢University of Washington / Fred Hutchinson Cancer Center🌐USA

Professor of Medicine

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Evan Yu is a prominent GU oncologist with extensive experience in urothelial and prostate cancer clinical trials. He has been an important contributor to the enfortumab vedotin clinical development program and novel combination strategies. His research focuses on optimizing treatment sequencing and identifying predictive biomarkers for ADC therapy.

Share:

🧪Research Fields 研究领域

Urothelial cancer
Prostate cancer
ADC therapeutics
Immunotherapy combinations
GU clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Evan Yu 的研究动态

Follow Evan Yu's research updates

留下邮箱,当我们发布与 Evan Yu(University of Washington / Fred Hutchinson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment